Cargando…
Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid
In search of anti-inflammatory compounds, novel scaffolds containing isonicotinoyl motif were synthesized via an efficient strategy. The compounds were screened for their in vitro anti-inflammatory activity. Remarkably high activities were observed for isonicotinates 5–6 and 8a–8b. The compound 5 ex...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956706/ https://www.ncbi.nlm.nih.gov/pubmed/33652837 http://dx.doi.org/10.3390/molecules26051272 |
_version_ | 1783664498038538240 |
---|---|
author | Yaqoob, Sana Nasim, Nourina Khanam, Rahila Wang, Yan Jabeen, Almas Qureshi, Urooj Ul-Haq, Zaheer El-Seedi, Hesham R. Jiang, Zi-Hua Khan, Farooq-Ahmad |
author_facet | Yaqoob, Sana Nasim, Nourina Khanam, Rahila Wang, Yan Jabeen, Almas Qureshi, Urooj Ul-Haq, Zaheer El-Seedi, Hesham R. Jiang, Zi-Hua Khan, Farooq-Ahmad |
author_sort | Yaqoob, Sana |
collection | PubMed |
description | In search of anti-inflammatory compounds, novel scaffolds containing isonicotinoyl motif were synthesized via an efficient strategy. The compounds were screened for their in vitro anti-inflammatory activity. Remarkably high activities were observed for isonicotinates 5–6 and 8a–8b. The compound 5 exhibits an exceptional IC(50) value (1.42 ± 0.1 µg/mL) with 95.9% inhibition at 25 µg/mL, which is eight folds better than the standard drug ibuprofen (11.2 ± 1.9 µg/mL). To gain an insight into the mode of action of anti-inflammatory compounds, molecular docking studies were also performed. Decisively, further development and fine tuning of these isonicotinates based scaffolds for the treatment of various aberrations is still a wide-open field of research. |
format | Online Article Text |
id | pubmed-7956706 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79567062021-03-16 Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid Yaqoob, Sana Nasim, Nourina Khanam, Rahila Wang, Yan Jabeen, Almas Qureshi, Urooj Ul-Haq, Zaheer El-Seedi, Hesham R. Jiang, Zi-Hua Khan, Farooq-Ahmad Molecules Communication In search of anti-inflammatory compounds, novel scaffolds containing isonicotinoyl motif were synthesized via an efficient strategy. The compounds were screened for their in vitro anti-inflammatory activity. Remarkably high activities were observed for isonicotinates 5–6 and 8a–8b. The compound 5 exhibits an exceptional IC(50) value (1.42 ± 0.1 µg/mL) with 95.9% inhibition at 25 µg/mL, which is eight folds better than the standard drug ibuprofen (11.2 ± 1.9 µg/mL). To gain an insight into the mode of action of anti-inflammatory compounds, molecular docking studies were also performed. Decisively, further development and fine tuning of these isonicotinates based scaffolds for the treatment of various aberrations is still a wide-open field of research. MDPI 2021-02-26 /pmc/articles/PMC7956706/ /pubmed/33652837 http://dx.doi.org/10.3390/molecules26051272 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Yaqoob, Sana Nasim, Nourina Khanam, Rahila Wang, Yan Jabeen, Almas Qureshi, Urooj Ul-Haq, Zaheer El-Seedi, Hesham R. Jiang, Zi-Hua Khan, Farooq-Ahmad Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid |
title | Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid |
title_full | Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid |
title_fullStr | Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid |
title_full_unstemmed | Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid |
title_short | Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid |
title_sort | synthesis of highly potent anti-inflammatory compounds (ros inhibitors) from isonicotinic acid |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956706/ https://www.ncbi.nlm.nih.gov/pubmed/33652837 http://dx.doi.org/10.3390/molecules26051272 |
work_keys_str_mv | AT yaqoobsana synthesisofhighlypotentantiinflammatorycompoundsrosinhibitorsfromisonicotinicacid AT nasimnourina synthesisofhighlypotentantiinflammatorycompoundsrosinhibitorsfromisonicotinicacid AT khanamrahila synthesisofhighlypotentantiinflammatorycompoundsrosinhibitorsfromisonicotinicacid AT wangyan synthesisofhighlypotentantiinflammatorycompoundsrosinhibitorsfromisonicotinicacid AT jabeenalmas synthesisofhighlypotentantiinflammatorycompoundsrosinhibitorsfromisonicotinicacid AT qureshiurooj synthesisofhighlypotentantiinflammatorycompoundsrosinhibitorsfromisonicotinicacid AT ulhaqzaheer synthesisofhighlypotentantiinflammatorycompoundsrosinhibitorsfromisonicotinicacid AT elseediheshamr synthesisofhighlypotentantiinflammatorycompoundsrosinhibitorsfromisonicotinicacid AT jiangzihua synthesisofhighlypotentantiinflammatorycompoundsrosinhibitorsfromisonicotinicacid AT khanfarooqahmad synthesisofhighlypotentantiinflammatorycompoundsrosinhibitorsfromisonicotinicacid |